Japan stock market week to March 19, 2007

25 March 2007

Tokyo gave up the previous week's strength and fell in the week ended March 19. The Nikkei 225 lost 1.6% following mixed movements, although the 17,000 mark was maintained at the close, while the Topix index dropped 2.7%. The market suffered a sharp daily setback mid-week, triggered by a tumble of New York markets with US concerns about increasing failures of subprime housing loans, but later staged a modest recovery following the rebound of US markets. Investors bought-back on the recent weakness of export-led stocks and domestic economy-based issues such as steel and machinery.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight